Harry W. Alcorn Jr - Jul 28, 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Chief Medical Officer
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
4
Date filed
7/29/2021, 09:14 PM
Next filing
Aug 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 8.26 K Jul 28, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +60 K $0.00 60 K Jul 28, 2021 Common Shares 60 K $5.00 Direct F1

Explanation of Responses:

Id Content
F1 Vests in sixteen nearly equal quarterly installments over four years.